As of November 2024, Santen Pharmaceutical has a market cap of $4.50B. This makes Santen Pharmaceutical the world's 3009th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.94B | 9.86% |
2023 | $3.59B | 30.82% |
2022 | $2.74B | -23.67% |
2021 | $3.59B | -16.00% |
2020 | $4.28B | -19.70% |
2019 | $5.33B | 31.53% |
2018 | $4.05B | -10.45% |
2017 | $4.52B | 23.85% |
2016 | $3.65B | -28.71% |
2015 | $5.12B | 55.02% |
2014 | $3.30B | 31.91% |
2013 | $2.50B | 48.86% |
2012 | $1.68B | 4.27% |
2011 | $1.61B | 11.82% |
2010 | $1.44B | -4.04% |
2009 | $1.50B | 8.67% |
2008 | $1.38B | -1.28% |
2007 | $1.40B | -18.06% |
2006 | $1.71B | 5.02% |
2005 | $1.63B | 42.41% |
2004 | $1.14B | 57.64% |
2003 | $725.64M | 29.42% |
2002 | $560.70M | -26.31% |
2001 | $760.88M | - |